Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease ornithine transcarbamylase deficiency
Comorbidity C0019204|hepatocellular carcinoma
Sentences 2
PubMedID- 22546217 Rharg exhibits significant cytotoxicity against cancer cells such as prostate cancer, melanoma, and hepatocellular carcinoma with oct deficiency.
PubMedID- 22129577 A 66 year old woman who is a manifesting heterozygote for ornithine transcarbamylase deficiency (otcd) presented with hepatocellular carcinoma (hcc).

Page: 1